Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.96 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.88 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.88 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.88 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.88 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.88 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.88 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.88 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.88 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.88 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.88 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.88 |
| ▸ | CNR1 | P21554 | 2/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | HTT | P42858 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30021084 | 0.94 | L3MBTL1 (0.84) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL1064050 | 0.94 | L3MBTL1 (0.84) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL30444656 | 0.94 | L3MBTL1 (0.84) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL10647695 | 0.94 | L3MBTL1 (0.84) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL9077076 | 0.94 | L3MBTL1 (0.84) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL23055044 | 0.94 | HDAC1 (1.00) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL12215287 | 0.94 | L3MBTL1 (0.84) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL27909129 | 0.94 | L3MBTL1 (0.84) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL8179797 | 0.92 | L3MBTL1 (0.82) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 | |
| SCHEMBL8134716 | 0.92 | L3MBTL1 (0.82) | L3MBTL1HDAC1HDAC8HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022092-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | COUNCIL SCIENT IND RES (IN) | 2026-01-22 | — | — | US | disclosed |
| WO-2024013769-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2024-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022092-A1 | PROCESS FOR SOLVENT FREE CONTINUOUS SYNTHESIS OF AMIDES AND PEPTIDES | TNF, VIP, APP | L3MBTL1 3868/4885HDAC1 3880/4885HDAC8 4043/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.